Rapid Infuser Device Market Research Report by Regional Analysis and forecast with upto 2024 Date: 03-06-2017 09:12 PM CET Category: Health & Medicine Press release from: Transparency Market Research - Medical Devices
Key players operating in the global rapid infuser devices market include 410 Medical, Inc., Belmont Instrument Corporation, Smisson-Cartledge Biomedical, LLC, and ZOLL Medical Corporation. Rapid infuser is a procedure/treatment which involves administration of rapid fluid used during surgical procedure. Rapid infuser device is able to deliver the fluid (human body fluid) from slow to rapid continuous flow. Rapid infuser device is prominently used in emergency situations for safe and effective treatment (when patients are admitted with hypovolemic shock or excessive blood loss). There are two prominent types of rapid infuser devices: one is driven by compressor, while the other is connected to hospital wall pressurized outlets. Rapid infuser device is mostly used for the following surgical procedures: Anesthesia and intensive care unit Emergency unit Obstetrics and gynecology Urology division Convenient and most effective way of delivering fluids in short span of time are the major factors deriving the global market. Moreover, use of this device in anesthesia centers have evolved over the years owing to product enhancements and application of information and sensing technology. Manufacturers in this industry are achieving innovation in patient care through integration of enhanced patient monitors, innovative parameters, wireless devices, workflows, and integrated IT solutions. This has enabled clinicians and anesthesiologists to practice and deliver customized services to patients. Manufacturing companies are not only providing technically advanced products, but also value added services such as predictable patient care, access to clinical information, and thus, optimized reimbursement. Moreover, rise in incidence of chronic pulmonary diseases is accelerating market growth. According to new estimates by the World Health Organization, COPD is predicted to become the third leading cause of death by 2030. An estimated 64 million people were suffering from COPD in 2004. Moreover, approximately 13.6 million adults were diagnosed with COPD in the U.S. alone. A rise in geriatric population
Seite 1 / 3